Skip to main content

Peer Review reports

From: Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma

Original Submission
13 Aug 2024 Submitted Original manuscript
21 Aug 2024 Reviewed Reviewer Report
21 Dec 2024 Reviewed Reviewer Report
6 Jan 2025 Author responded Author comments - Eman A. Madbouly
16 Jan 2025 Reviewed Reviewer Report
3 Feb 2025 Reviewed Reviewer Report
7 Feb 2025 Author responded Author comments - Eman A. Madbouly
Resubmission - Version 2
6 Jan 2025 Submitted Manuscript version 2
28 Feb 2025 Reviewed Reviewer Report
14 Mar 2025 Author responded Author comments - Eman A. Madbouly
Resubmission - Version 3
14 Mar 2025 Submitted Manuscript version 3
4 Apr 2025 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
7 Apr 2025 Editorially accepted
2 May 2025 Article published 10.1186/s13065-025-01480-8

You can find further information about peer review here.

Back to article page